RecruitingNot Applicable

Ovarian Stimulation Outcomes During a GnRH Antagonist Protocol for In-vitro Fertilization When Comparing Trigger Day Decision by Physicians Versus an Artificial Intelligence-based Algorithm.

Israel180 participantsStarted 2025-05-21

Plain-language summary

To compare the number of mature oocytes following a GnRH antagonist in-vitro fertilization stimulation cycle when comparing trigger day timing decision by physicians versus an artificial intelligence-based algorithm

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients undergoing an ovarian stimulation cycle utilizing the GnRH antagonist protocol for oocyte cryopreservation or for fertilization via intracytoplasmic sperm injection (ICSI) (any treatment where oocytes are denuded and maturity may be assessed). Exclusion Criteria: * Loss to follow-up, patient retracts consent to participate

What they're measuring

Mature oocyte yield

Timeframe: 2 years

Trial details

NCT IDNCT07110285

SponsorFertilAI

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-05

Contact for this trial

Michal Youngster, MD

+972-50-643-0111 michalyo@gmail.com

View on ClinicalTrials.gov More IVF Outcomes trials